Wooten Ronald J Insider Trades

Insider Trading History

Track insider trading activity for Wooten Ronald J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Director
Holding Value $353k 830,294 shares
Last Trade
Jan 17, 2023 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$353k 830,294 shares
$0.42
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Director
Holding Value $0 0 shares
Last Trade
Jan 17, 2023 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$6k 14,115 shares
$0.42
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Director
Holding Value $6k 14,115 shares
Last Trade
Sep 28, 2022 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$5.42k 14,115 shares
$0.38
$0.42
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $29.2k 8,000 shares
Last Trade
May 07, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 8,000 shares
$20.42
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $29.2k 8,000 shares
Last Trade
May 07, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$163k 8,000 shares
$20.42
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $29.2k 8,000 shares
Last Trade
Apr 08, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$231k 8,000 shares
$28.93
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $9.85M 2,697,933 shares
Last Trade
Feb 11, 2014 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$17.5M 658,551 shares
$26.60
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $7.44M 2,039,382 shares
Last Trade
Feb 11, 2014 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$54.2M 2,039,382 shares
$26.60
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $0 0 shares
Last Trade
Feb 11, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$40.9M 1,539,343 shares
$26.60
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $0 0 shares
Last Trade
Feb 11, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$17.5M 658,551 shares
$26.60
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $0 0 shares
Last Trade
Feb 11, 2014 Sale (In The Money)Reported as In The Money on SEC Form 4.
$10.6M 398,717 shares
$26.60
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $11.3M 3,096,650 shares
Last Trade
Feb 11, 2014 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$10.6M 398,717 shares
$26.60
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $0 0 shares
Last Trade
Feb 11, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$40.9M 1,539,343 shares
$26.60
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $0 0 shares
Last Trade
Feb 05, 2014 Sale
No data
No data
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $0 0 shares
Last Trade
Feb 05, 2014 Sale
No data
No data
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $0 0 shares
Last Trade
Feb 05, 2014 Sale
No data
No data
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
10% owner
Holding Value $0 0 shares
Last Trade
Feb 05, 2014 Sale
No data
No data
$3.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up